These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8068876)

  • 41. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes.
    Nielsen CH; Matthiesen SH; Lyng I; Leslie RG
    Immunology; 1997 Jan; 90(1):129-37. PubMed ID: 9038723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene.
    Wilson JG; Wong WW; Murphy EE; Schur PH; Fearon DT
    J Immunol; 1987 Apr; 138(8):2708-10. PubMed ID: 2881967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of complement receptor type 1-related proteins on primate erythrocytes.
    Nickells MW; Subramanian VB; Clemenza L; Atkinson JP
    J Immunol; 1995 Mar; 154(6):2829-37. PubMed ID: 7876553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
    Iida K; Mornaghi R; Nussenzweig V
    J Exp Med; 1982 May; 155(5):1427-38. PubMed ID: 6978375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Erythrocyte complement receptors.
    Birmingham DJ
    Crit Rev Immunol; 1995; 15(2):133-54. PubMed ID: 8573285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced erythrocyte complement receptor type 1 in systemic lupus erythematosus is related to a disease activity index and not to the presence or severity of renal disease.
    de Carvalho Lins CE; Pereira Crott LS; Teixeira JE; Barbosa JE
    Lupus; 2004; 13(7):517-21. PubMed ID: 15352423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
    Madi N; Paccaud JP; Steiger G; Schifferli JA
    Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
    J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).
    Reilly BD; Mold C
    Clin Exp Immunol; 1997 Nov; 110(2):310-6. PubMed ID: 9367418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced erythrocyte CR1 (CD 35) receptor function and complement opsonization in factor I-deficient patients is restored by plasma infusion.
    Jepsen HH; Teisner B; Rasmussen JM; Svehag SE
    Scand J Immunol; 1989 Feb; 29(2):247-55. PubMed ID: 2522236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erythrocyte CR1 (C3b/C4b receptor) levels and disease activity in patients with SLE.
    Thomsen BS; Nielsen H; Andersen V
    Scand J Rheumatol; 1987; 16(5):339-46. PubMed ID: 2961056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).
    Masaki T; Matsumoto M; Nakanishi I; Yasuda R; Seya T
    J Biochem; 1992 May; 111(5):573-8. PubMed ID: 1386357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus.
    Moldenhauer F; David J; Fielder AH; Lachmann PJ; Walport MJ
    Arthritis Rheum; 1987 Sep; 30(9):961-6. PubMed ID: 2959289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The expression of C3b receptors in the differentiation of discoid lupus erythematosus and systemic lupus erythematosus.
    Tausk F; Harpster E; Gigli I
    Arthritis Rheum; 1990 Jun; 33(6):888-92. PubMed ID: 2141982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA; Ng YC; Paccaud JP; Walport MJ
    Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE).
    Csípö I; Kiss E; Soltész P; Antal-Szalmás P; Szegedi G; Cohen JH; Taylor RP; Kávai M
    Clin Exp Immunol; 1999 Dec; 118(3):458-64. PubMed ID: 10594568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry.
    Kisserli A; Audonnet S; Duret V; Tabary T; Cohen JHM; Mahmoudi R
    J Vis Exp; 2020 May; (159):. PubMed ID: 32510517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.
    Yoon SH; Fearon DT
    J Immunol; 1985 May; 134(5):3332-8. PubMed ID: 3156931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Erythrocyte CR1 receptor reactivity in patients with systemic lupus erythematosus].
    Said PB; Sarano J; Manni JA; Casellas AM
    Medicina (B Aires); 1990; 50(1):21-4. PubMed ID: 2149869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum complement activation of SLE patients during plasmapheresis.
    Csipö I; Kávai M; Kiss E; Bedö Z; Csongor J; Szegedi G; Philbert F; Cohen JH
    Autoimmunity; 1997; 25(3):139-46. PubMed ID: 9272279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.